BLISS GVS PHARMA
Back to Income Statement
|
BLISS GVS PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹620 Cr | ₹634 Cr | ₹629 Cr | ₹471 Cr | ₹566 Cr |
What is the latest Total Expenditure of BLISS GVS PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹620 Cr |
| Mar2024 | ₹634 Cr |
| Mar2023 | ₹629 Cr |
| Mar2022 | ₹471 Cr |
| Mar2021 | ₹566 Cr |
How is Total Expenditure of BLISS GVS PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹620 Cr | -2.31 | |
| Mar2024 | ₹634 Cr | 0.82 | |
| Mar2023 | ₹629 Cr | 33.69 | |
| Mar2022 | ₹471 Cr | -16.86 | |
| Mar2021 | ₹566 Cr | - | |
Compare Total Expenditure of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹2,778.3 Cr | 3.6% | 24.5% | 116.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 3.6% |
24.5% |
116.4% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses